Fellowship · Houston, TX
Sponsored by University of Texas M D Anderson Cancer Center
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.
Leukemia · 2022 · 3,530 citations · Wei-Lien Wang
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.
The New England journal of medicine · 2023 · 739 citations · Victor Prieto
Dermatofibrosarcoma Protuberans, Version 1.2025, NCCN Clinical Practice Guidelines In Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2025 · 80 citations · Valencia Thomas
Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity.
Cancer cell · 2022 · 318 citations · Jonathan Curry
Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy.
Nature · 2025 · 72 citations · Priyadharsini Nagarajan
Neoadjuvant relatlimab and nivolumab in resectable melanoma.
Nature · 2022 · 292 citations · Carlos Torres-Cabala, Victor Prieto
Basal Cell Skin Cancer, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 103 citations · Valencia Thomas
Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease.
JAMA oncology · 2022 · 123 citations · Phyu Aung, Valencia Thomas